Guo Yan-Mei, Wang Qin, Liu Yan-Zhen, Chen Huei-Min, Qi Zhi, Guo Qing-Hong
Department of Clinical Medicine, Gansu College of Traditional Chinese Medicine, Lanzhou 730000, Gansu Province, China.
World J Gastroenterol. 2008 Mar 7;14(9):1444-9. doi: 10.3748/wjg.14.1444.
To evaluate the association between genetic polymorphisms in CYP2E1, ALDH2 and ADH1B and the risk of esophageal squamous cell carcinoma (ESCC) in a high risk area of Gansu Province, in Chinese males.
A case-control study was conducted to investigate the genetic polymorphisms of these enzymes (CYP2E1*c1/c2, ALDH21/*2 and ADH1B *1/*1 genotypes). A total of 80 esophageal cancer cases and 480 controls were recruited.
Compared with controls, cases had a greater prevalence of heavier alcohol consumption (53.8% vs 16.2%) and a higher proportion of alcohol drinkers with >30 drink-years (28.8% vs 13.5%). Heavier alcohol consumption and alcohol drinking with >30 drink-years increased the risk of ESCC, with ORs (95% CI) of 3.20 (1.32-9.65) and 1.68 (0.96-3.21). CYP2E1 (*c1/*c1), ALDH2 (*1/*2) and ADH1B (*1/1) genotype frequencies were higher among patients with squamous cell carcinomas, at a level close to statistical significance (P=0.014; P=0.094; P=0.0001 respectively). There were synergistic interactions among alcohol drinking and ALDH2, ADH1B and CYP2E1 genotypes. The risk of the ESCC in moderate-to-heavy drinkers with an inactive ALDH2 encoded by ALDH21/*2 as well as ADH1B encoded by ADH1B *1/*1 and CYP2E1 encoded by CYP2E1 *c1/*c1 was higher than that in the never/rare-to-light drinkers with an active ALDH2 (*1/*1 genotype) as well as ADH1B (*1/*2+*2/*2) and CYP2E1 (*c1/*c2+*c2/*c2) genotypes, with a statistically significant difference; ORs (95% CI) of 8.58 (3.28-22.68), 27.12 (8.52-70.19) and 7.64 (2.82-11.31) respectively. The risk of the ESCC in moderate-to-heavy drinkers with ALDH2 (*1/*2) combined the ADH1B (*1/*1) genotype or ALDH2 (*1/*2) combined the CYP2E1 (*c1/*c1) genotype leads to synergistic interactions, higher than drinkers with ALDH2 (*1/*1)+ADH1B (*1/*2+*2/*2), ALDH2 (*1/*1)+CYP2E1 (*c1/*c2+*c2/*c2) respectively , ORs (95% CI) of 7.46 (3.28-18.32) and 6.82 (1.44-9.76) respectively. Individuals with the ADH1B combined the CYP2E1 genotype showed no synergistic interaction.
In our study, we found that alcohol consumption and polymorphisms in the CYP2E1, ADH1B and ALDH2 genes are important risk factors for ESCC, and that there was a synergistic interaction among polymorphisms in the CYP2E1, ALDH2 and ADH1B genes and heavy alcohol drinking, in Chinese males living in Gansu Province, China.
评估甘肃省高危地区中国男性中,细胞色素P450 2E1(CYP2E1)、乙醛脱氢酶2(ALDH2)和乙醇脱氢酶1B(ADH1B)基因多态性与食管鳞状细胞癌(ESCC)风险之间的关联。
开展一项病例对照研究,调查这些酶(CYP2E1*c1/c2、ALDH21/*2和ADH1B *1/*1基因型)的基因多态性。共招募了80例食管癌病例和480例对照。
与对照组相比,病例组中重度饮酒的患病率更高(53.8%对16.2%),且饮酒年限>30年的饮酒者比例更高(28.8%对13.5%)。重度饮酒和饮酒年限>30年增加了ESCC的风险,比值比(OR)(95%置信区间)分别为3.20(1.32 - 9.65)和1.68(0.96 - 3.21)。CYP2E1(*c1/*c1)、ALDH2(*1/*2)和ADH1B(*1/1)基因型频率在鳞状细胞癌患者中更高,接近统计学显著性水平(分别为P = 0.014;P = 0.094;P = 0.0001)。饮酒与ALDH2、ADH1B和CYP2E1基因型之间存在协同相互作用。携带由ALDH21/*2编码的无活性ALDH2以及由ADH1B *1/*1编码的ADH1B和由CYP2E1 *c1/*c1编码的CYP2E1的中度至重度饮酒者患ESCC的风险高于携带活性ALDH2(*1/*1基因型)以及ADH1B(*1/*2 + *2/*2)和CYP2E1(*c1/*c2 + *c2/*c2)基因型的从不/偶尔/轻度饮酒者,差异具有统计学显著性;OR(95%置信区间)分别为8.58(3.28 - 22.68)、27.12(8.52 - 70.19)和7.64(2.82 - 11.31)。携带ALDH2(*1/*2)合并ADH1B(*1/*1)基因型或ALDH2(*1/*2)合并CYP2E1(*c1/*c1)基因型的中度至重度饮酒者患ESCC的风险存在协同相互作用,高于分别携带ALDH2(*1/*1) + ADH1B(*1/*2 + *2/*2)、ALDH2(*1/*1) + CYP2E1(*c1/*c2 + *c2/*c2)的饮酒者,OR(95%置信区间)分别为7.46(3.28 - 18.32)和6.82(1.44 - 9.76)。携带ADH1B合并CYP2E1基因型的个体未显示协同相互作用。
在我们的研究中,我们发现饮酒以及CYP2E1、ADH1B和ALDH2基因多态性是ESCC的重要危险因素,并且在中国甘肃省居住的中国男性中,CYP2E1、ALDH2和ADH1B基因多态性与重度饮酒之间存在协同相互作用。